Artax Biopharma Inc., of Cambridge, Mass., appointed Balbino Alarcón, Raif Geha, Menno de Rie, Lawrence Steinman and Cox Terhorst to its scientific advisory board. Alarcón will serve as chair.
Bridgebio Pharma Inc., of Palo Alto, Calif., appointed Brent Saunders, Randy Scott and Andrew Lo to its board.
Cytovia Therapeutics Inc., of New York, appointed Leila Alland and Jane Wasman to its board.
Nascent Biotech Inc., of San Diego, appointed Navpaul Singh chief medical consultant in charge of COVID-19 research.
Neuraptive Therapeutics Inc., of Philadelphia, appointed Robert S. Radie CEO and chair of its board.